Costly Med Devices Lying Idle In Hospitals Due To Infra, Manpower Crunch: CAG

Bhubaneswar:  Lack of infrastructure and manpower shortage are responsible for costly equipment and medical devices like ventilators and oxygen concentrators to lie idle or non-functional in several hospitals across the state, the CAG has observed.

According to the report tabled in the assembly, Odisha State Medical Corporation Limited (OSMCL) had supplied 402 ICU ventilators, worth around Rs 11.77 crore, to 13 private hospitals for treatment of Covid patients. After the pandemic, these ventilators were to be returned to the government.

“It was, however, noticed that these ventilators were not returned by the private hospitals. During inspection of 10 such hospitals, these ventilators were found to be lying in the stores of these private hospitals,” the CAG report stated.

It also said that OSMCL had supplied 817 Multipara monitors, costing nearly Rs 10.95 crore, to 12 private hospitals which were lying with them. The CAG found that 57 kinds of equipment received from OSMCL, National Health Mission (NHM) and PM Cares, were lying in the sub-stores of three district headquarters hospitals (DHH)s — Bhadrak, Dhenkanal and Sundargarh — without having been installed.

One laparoscopic unit, costing Rs 20.89 lakh, was lying idle at DHH, Puri, since March 2006 due to lack of trained technical staff. Similarly, one Remidio digital Fundus camera (Rs 4.97 lakh), that DHH, Nabarangpur had got in Nov 2021, was not put to use in the absence of an ophthalmologist and an ophthalmic assistant.

“Scrutiny of records and joint physical inspection of clinical and non-clinical departments of two surveyed medical colleges and hospitals (MCH) revealed that 553 items of equipment, costing Rs 17.76 crore, remained idle or defunct,” the report stated, without naming the healthcare institutions.

Related Posts

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

The report emphasizes that absolute R&D spending remains modest and identifies expanding investment in advanced biologics and AI-driven drug discovery as the “largest opportunity” for bridging the innovation divide. Recent…

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Early-stage activity drove the month, accounting for 73.6 per cent of total investments, while seed-stage rounds contributed the remaining 26.4 per cent. India’s pharma and healthcare funding for November 2025…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Novo Nordisk gears up for December Ozempic launch

Novo Nordisk gears up for December Ozempic launch

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit